News about "Voluntary Action Indicated (VAI)"

USFDA Concludes Inspection at Dr. Reddy's Srikakulam Facility with VAI Classification

USFDA Concludes Inspection at Dr. Reddy's Srikakulam Facility with VAI Classification

Dr. Reddy’s Laboratories has announced that the United States Food and Drug Administration (USFDA) has completed a Good Manufacturing Practice (GMP) and Pre-Approval Inspection (PAI) at its formulations manufacturing facility (FTO 11) in Srikakulam, Andhra Pradesh.

Voluntary Action Indicated (VAI) | 21/10/2025 | By Dineshwori 134

NATCO Pharma's Kothur Facility Receives FDA EIR with VAI Classification

NATCO Pharma's Kothur Facility Receives FDA EIR with VAI Classification

The US Food and Drug Administration (FDA) has completed an inspection at NATCO Pharma’s Pharma division located in Kothur, Hyderabad, India.

Voluntary Action Indicated (VAI) | 18/09/2025 | By Dineshwori 233


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members